Amedisys, Inc. (AMED)
USD 84.97
(-0.47%)
USD 84.97
(-0.47%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 834.47 Million USD | -66.11% |
| 2022 | 778.99 Million USD | 6.88% |
| 2021 | 728.84 Million USD | 9.98% |
| 2020 | 662.73 Million USD | 5.81% |
| 2019 | 626.35 Million USD | 21.72% |
| 2018 | 514.56 Million USD | -1.87% |
| 2017 | 524.39 Million USD | -3.36% |
| 2016 | 542.62 Million USD | 11.53% |
| 2015 | 486.52 Million USD | 0.04% |
| 2014 | 486.33 Million USD | -7.69% |
| 2013 | 526.82 Million USD | -11.73% |
| 2012 | 596.86 Million USD | -48.5% |
| 2011 | 1.15 Billion USD | 86.81% |
| 2010 | 620.34 Million USD | 11.12% |
| 2009 | 558.24 Million USD | 19.36% |
| 2008 | 467.68 Million USD | 59.82% |
| 2007 | 292.63 Million USD | 21.92% |
| 2006 | 240.03 Million USD | 42.52% |
| 2005 | 168.42 Million USD | 72.51% |
| 2004 | 97.63 Million USD | 40.32% |
| 2003 | 69.58 Million USD | 10.34% |
| 2002 | 63.06 Million USD | 17.51% |
| 2001 | 53.66 Million USD | 8.96% |
| 2000 | 49.25 Million USD | -7.33% |
| 1999 | 53.14 Million USD | 19.59% |
| 1998 | 44.44 Million USD | 81.81% |
| 1997 | 24.44 Million USD | 32.04% |
| 1996 | 18.51 Million USD | 28.55% |
| 1995 | 14.4 Million USD | 63.64% |
| 1994 | 8.8 Million USD | 83.33% |
| 1993 | 4.8 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 65.37 Million USD | -87.82% |
| 2024 Q2 | 66.43 Million USD | 1.62% |
| 2023 FY | 264.01 Million USD | -66.11% |
| 2023 Q4 | 536.77 Million USD | 171.9% |
| 2023 Q1 | 199 Million USD | 0.17% |
| 2023 Q2 | 217.71 Million USD | 9.41% |
| 2023 Q3 | 197.41 Million USD | -9.32% |
| 2022 Q4 | 198.65 Million USD | 2.5% |
| 2022 Q2 | 194.03 Million USD | 0.81% |
| 2022 Q1 | 192.47 Million USD | -0.78% |
| 2022 Q3 | 193.82 Million USD | -0.11% |
| 2022 FY | 778.99 Million USD | 6.88% |
| 2021 Q4 | 193.99 Million USD | 4.06% |
| 2021 FY | 728.84 Million USD | 9.98% |
| 2021 Q1 | 171.09 Million USD | -3.7% |
| 2021 Q2 | 177.34 Million USD | 3.65% |
| 2021 Q3 | 186.41 Million USD | 5.12% |
| 2020 Q3 | 183.08 Million USD | 30.87% |
| 2020 Q4 | 177.66 Million USD | -2.96% |
| 2020 Q2 | 139.89 Million USD | -13.68% |
| 2020 Q1 | 162.07 Million USD | 0.02% |
| 2020 FY | 662.73 Million USD | 5.81% |
| 2019 Q1 | 147.74 Million USD | 8.87% |
| 2019 FY | 626.35 Million USD | 21.72% |
| 2019 Q2 | 157.48 Million USD | 6.59% |
| 2019 Q3 | 159.07 Million USD | 1.01% |
| 2019 Q4 | 162.05 Million USD | 1.87% |
| 2018 Q1 | 124.94 Million USD | -7.2% |
| 2018 Q2 | 126.21 Million USD | 1.01% |
| 2018 Q4 | 135.7 Million USD | 6.26% |
| 2018 Q3 | 127.7 Million USD | 1.19% |
| 2018 FY | 514.56 Million USD | -1.87% |
| 2017 Q4 | 134.63 Million USD | 3.45% |
| 2017 FY | 524.39 Million USD | -3.36% |
| 2017 Q1 | 129.5 Million USD | -4.57% |
| 2017 Q2 | 130.1 Million USD | 0.46% |
| 2017 Q3 | 130.14 Million USD | 0.03% |
| 2016 Q2 | 135.88 Million USD | -0.03% |
| 2016 Q4 | 135.71 Million USD | 0.45% |
| 2016 Q1 | 135.91 Million USD | 5.21% |
| 2016 Q3 | 135.11 Million USD | -0.57% |
| 2016 FY | 542.62 Million USD | 11.53% |
| 2015 Q3 | 120.88 Million USD | -1.66% |
| 2015 Q4 | 129.18 Million USD | 6.87% |
| 2015 Q2 | 122.92 Million USD | 8.28% |
| 2015 Q1 | 113.52 Million USD | 0.07% |
| 2015 FY | 486.52 Million USD | 0.04% |
| 2014 Q4 | 113.44 Million USD | -0.38% |
| 2014 Q2 | 119.92 Million USD | -13.78% |
| 2014 FY | 486.33 Million USD | -7.69% |
| 2014 Q3 | 113.87 Million USD | -5.05% |
| 2014 Q1 | 139.09 Million USD | 11.85% |
| 2013 Q2 | 133.27 Million USD | -6.47% |
| 2013 FY | 526.82 Million USD | -11.73% |
| 2013 Q4 | 124.35 Million USD | -4.67% |
| 2013 Q3 | 130.44 Million USD | -2.12% |
| 2013 Q1 | 142.5 Million USD | -4.68% |
| 2012 FY | 596.86 Million USD | -48.5% |
| 2012 Q1 | 149.87 Million USD | 3.97% |
| 2012 Q2 | 150.68 Million USD | 0.54% |
| 2012 Q3 | 146.81 Million USD | -2.57% |
| 2012 Q4 | 149.49 Million USD | 1.83% |
| 2011 Q3 | 726.52 Million USD | 409.61% |
| 2011 FY | 1.15 Billion USD | 86.81% |
| 2011 Q1 | 145.64 Million USD | -6.02% |
| 2011 Q4 | 144.14 Million USD | -80.16% |
| 2011 Q2 | 142.56 Million USD | -2.11% |
| 2010 Q1 | 147.19 Million USD | 1.83% |
| 2010 Q2 | 156.91 Million USD | 6.61% |
| 2010 Q3 | 161.26 Million USD | 2.77% |
| 2010 Q4 | 154.97 Million USD | -3.89% |
| 2010 FY | 620.34 Million USD | 11.12% |
| 2009 FY | 558.24 Million USD | 19.36% |
| 2009 Q4 | 144.54 Million USD | 0.45% |
| 2009 Q3 | 143.9 Million USD | 2.85% |
| 2009 Q2 | 139.91 Million USD | 7.73% |
| 2009 Q1 | 129.88 Million USD | -1.03% |
| 2008 Q3 | 126.8 Million USD | 1.31% |
| 2008 Q4 | 131.23 Million USD | 3.5% |
| 2008 FY | 467.68 Million USD | 59.82% |
| 2008 Q2 | 125.16 Million USD | 48.16% |
| 2008 Q1 | 84.48 Million USD | 5.4% |
| 2007 Q1 | 65.85 Million USD | 6.59% |
| 2007 FY | 292.63 Million USD | 21.92% |
| 2007 Q4 | 80.15 Million USD | 5.64% |
| 2007 Q3 | 75.87 Million USD | 7.23% |
| 2007 Q2 | 70.75 Million USD | 7.45% |
| 2006 Q4 | 61.78 Million USD | 4.72% |
| 2006 Q3 | 58.99 Million USD | -2.57% |
| 2006 Q2 | 60.55 Million USD | 3.17% |
| 2006 Q1 | 58.69 Million USD | 7.63% |
| 2006 FY | 240.03 Million USD | 42.52% |
| 2005 Q2 | 34.29 Million USD | 12.58% |
| 2005 FY | 168.42 Million USD | 72.51% |
| 2005 Q4 | 54.53 Million USD | 11.02% |
| 2005 Q3 | 49.12 Million USD | 43.24% |
| 2005 Q1 | 30.46 Million USD | 12.5% |
| 2004 Q2 | 25.2 Million USD | 20.26% |
| 2004 Q4 | 27.07 Million USD | 10.97% |
| 2004 Q3 | 24.4 Million USD | -3.17% |
| 2004 Q1 | 20.95 Million USD | 10.01% |
| 2004 FY | 97.63 Million USD | 40.32% |
| 2003 Q3 | 17.95 Million USD | 8.58% |
| 2003 Q2 | 16.53 Million USD | 3.11% |
| 2003 FY | 69.58 Million USD | 10.34% |
| 2003 Q1 | 16.03 Million USD | -6.59% |
| 2003 Q4 | 19.04 Million USD | 6.07% |
| 2002 Q3 | 15.58 Million USD | 1.76% |
| 2002 Q2 | 15.31 Million USD | 2.19% |
| 2002 FY | 63.06 Million USD | 17.51% |
| 2002 Q4 | 17.17 Million USD | 10.18% |
| 2002 Q1 | 14.98 Million USD | 6.35% |
| 2001 Q3 | 14.05 Million USD | 6.24% |
| 2001 Q4 | 14.09 Million USD | 0.26% |
| 2001 FY | 53.66 Million USD | 8.96% |
| 2001 Q1 | 13.18 Million USD | 24.9% |
| 2001 Q2 | 13.23 Million USD | 0.36% |
| 2000 FY | 49.25 Million USD | -7.33% |
| 2000 Q4 | 10.55 Million USD | -16.12% |
| 2000 Q1 | 12.87 Million USD | 8.18% |
| 2000 Q3 | 12.58 Million USD | -4.95% |
| 2000 Q2 | 13.24 Million USD | 2.85% |
| 1999 Q3 | 13.6 Million USD | -2.86% |
| 1999 FY | 53.14 Million USD | 19.59% |
| 1999 Q4 | 11.9 Million USD | -12.5% |
| 1999 Q2 | 14 Million USD | 2.41% |
| 1999 Q1 | 13.67 Million USD | 2.47% |
| 1998 Q4 | 13.34 Million USD | -13.93% |
| 1998 Q1 | 9.1 Million USD | 19.06% |
| 1998 FY | 44.44 Million USD | 81.81% |
| 1998 Q2 | 8.3 Million USD | -8.79% |
| 1998 Q3 | 15.5 Million USD | 86.75% |
| 1997 Q3 | 6.2 Million USD | 14.81% |
| 1997 FY | 24.44 Million USD | 32.04% |
| 1997 Q4 | 7.64 Million USD | 23.27% |
| 1997 Q1 | 5.2 Million USD | 15.26% |
| 1997 Q2 | 5.4 Million USD | 3.85% |
| 1996 Q2 | 4.8 Million USD | 11.63% |
| 1996 Q3 | 4.9 Million USD | 2.08% |
| 1996 Q4 | 4.51 Million USD | -7.92% |
| 1996 FY | 18.51 Million USD | 28.55% |
| 1996 Q1 | 4.3 Million USD | 2.38% |
| 1995 Q2 | 3.4 Million USD | 25.93% |
| 1995 Q1 | 2.7 Million USD | 111.11% |
| 1995 FY | 14.4 Million USD | 63.64% |
| 1995 Q4 | 4.2 Million USD | 7.69% |
| 1995 Q3 | 3.9 Million USD | 14.71% |
| 1994 FY | 8.8 Million USD | 83.33% |
| 1994 Q4 | -24.3 Million USD | 0.0% |
| 1994 Q1 | 2 Million USD | 114.29% |
| 1994 Q2 | 2.3 Million USD | 15.0% |
| 1994 Q3 | - USD | -100.0% |
| 1993 FY | 4.8 Million USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1993 Q4 | -14 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | -374.101% |
| Addus HomeCare Corporation | 248.92 Million USD | -235.24% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | -605.261% |
| American Oncology Network, Inc. | 83.97 Million USD | -893.723% |
| Astrana Health, Inc. | 112.59 Million USD | -641.12% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | -42.073% |
| IMAC Holdings, Inc. | 5.02 Million USD | -16499.524% |
| biote Corp. | 98.82 Million USD | -744.392% |
| Cryo-Cell International, Inc. | 35.2 Million USD | -2270.314% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | -147.109% |
| COMPASS Pathways plc | 136.91 Million USD | -509.469% |
| DocGo Inc. | 180.32 Million USD | -362.758% |
| The Ensign Group, Inc. | 335.39 Million USD | -148.807% |
| Healthcare Services Group, Inc. | 189.09 Million USD | -341.308% |
| InnovAge Holding Corp. | 558.25 Million USD | -49.48% |
| Assure Holdings Corp. | 15.43 Million USD | -5305.007% |
| The Joint Corp. | 109.22 Million USD | -664.015% |
| LifeStance Health Group, Inc. | 491.23 Million USD | -69.875% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -4474.463% |
| ModivCare Inc. | 586.89 Million USD | -42.185% |
| NewGenIvf Group Limited | 1.63 Million USD | -50797.049% |
| Novo Integrated Sciences, Inc. | 13.5 Million USD | -6078.636% |
| Option Care Health, Inc. | 666.62 Million USD | -25.179% |
| P3 Health Partners Inc. | 199.56 Million USD | -318.149% |
| P3 Health Partners Inc. | 199.56 Million USD | -318.149% |
| The Pennant Group, Inc. | 88.99 Million USD | -837.67% |
| Surgery Partners, Inc. | 319.5 Million USD | -161.183% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -19308.75% |
| Talkspace, Inc. | 97.58 Million USD | -755.095% |
| Talkspace, Inc. | 97.58 Million USD | -755.095% |
| The Oncology Institute, Inc. | 136.59 Million USD | -510.933% |
| The Oncology Institute, Inc. | 136.59 Million USD | -510.933% |